20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Innovations in Chemical Synthesis: The Production of Butylated Hydroxytoluene (BHT) by NINGBO INNO PHARMCHEM CO.,LTD.

The effectiveness of Butylated Hydroxytoluene (BHT) as an antioxidant is deeply rooted in its precise chemical structure, achieved through sophisticated industrial synthesis. At NINGBO INNO PHARMCHEM CO.,LTD., we are proud to be part of this innovation, supplying high-quality BHT derived from carefully controlled manufacturing processes. Understanding the chemical synthesis of BHT sheds light on its reliability and performance.

The primary industrial route for producing BHT involves the catalytic reaction of p-cresol (4-methylphenol) with isobutylene (2-methylpropene). This process, typically catalyzed by sulfuric acid, yields the desired 2,6-di-tert-butyl-4-methylphenol. The precise control of reaction conditions – temperature, pressure, and catalyst concentration – is paramount to achieving high purity and yield, which are hallmarks of the synthetic antioxidant BHT properties that our clients rely on. NINGBO INNO PHARMCHEM CO.,LTD. ensures stringent quality control at every stage of production.

Alternative synthesis pathways also exist, sometimes involving the modification of 2,6-di-tert-butylphenol. These methods further underscore the chemical engineering expertise involved in producing BHT. The resulting molecule is a highly effective free radical scavenger, a property that dictates its broad range of applications. From protecting food from spoilage to stabilizing industrial lubricants, the reliable supply of BHT is critical. Companies seeking to purchase BHT can trust NINGBO INNO PHARMCHEM CO.,LTD. for consistently high-quality material produced through advanced chemical synthesis.

The continuous pursuit of efficiency and sustainability in chemical manufacturing is a key focus for NINGBO INNO PHARMCHEM CO.,LTD. We are dedicated to optimizing our production processes to meet market demands while adhering to environmental best practices. Our commitment to excellence in the chemical synthesis of BHT ensures that we remain a leading supplier in the global chemical market.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Understanding BHT's Impact: Health Effects and Regulatory Landscape - A NINGBO INNO PHARMCHEM CO.,LTD. Overview

Next: Understanding Binimetinib: A Key Player in Targeted Cancer Therapy

All Rights Reserved